Monashee Investment Management LLC Caribou Biosciences, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$5.1 - $9.74 $2.4 Million - $4.58 Million
-470,000 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$8.42 - $15.32 $289,454 - $526,655
-34,377 Reduced 6.82%
470,000 $4.32 Million
Q4 2021

Feb 07, 2022
BUY
$14.59 - $23.26 $802,450 - $1.28 Million
55,000 Added 12.24%
504,377 $7.61 Million
Q3 2021

Nov 09, 2021
BUY
$15.75 - $30.29 $7.08 Million - $13.6 Million
449,377 New
449,377 $10.7 Million

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $91.9M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email